The Effects of Brain-derived Neurotrophic Factor on Insulin Signal Transduction in the Liver of Diabetic Mice
Overview
Affiliations
Aim/hypothesis: We previously reported that repeated subcutaneous or intracerebroventricular injection of brain-derived neurotrophic factor (BDNF) reduces blood glucose concentrations in obese diabetic C57BL/KsJ-db/db mice. In this study, we assessed the effects of BDNF on insulin action in peripheral tissues of diabetic mice.
Methods: First, brain-derived neurotrophic factor (20 mg/kg) was subcutaneously given to male db/db mice for 14 days and then the insulin-stimulated tyrosine phosphorylation of insulin receptors and insulin-stimulated phosphatidylinositol (PI) 3-kinase activity in peripheral tissues was assessed. Second, we examined the effects of a single subcutaneous or intracerebroventricular brain-derived neurotrophic factor injection on insulin responsiveness in liver and skeletal muscle of streptozotocin (STZ)-induced diabetic mice. Third, the effects of brain-derived neurothrophic factor on insulin action were also examined in cultured cells.
Results: Repeated injection of BDNF to db/db mice for 14 days enhanced insulin-stimulated tyrosine phosphorylation of insulin receptors in liver and insulin-stimulated PI 3-kinase activity in liver, skeletal muscle and interscapular brown adipose tissue. We then examined the rapid effect of BDNF on insulin signalling in vivo. A single subcutaneous or intracerebroventricular injection of BDNF rapidly increased insulin-stimulated tyrosine phosphorylation of insulin receptors and PI 3-kinase activity in liver of STZ-mice. No direct effect of brain-derived neurothrophic factor was observed on insulin signalling in primary cultured hepatocytes, L6 muscle cells or 3T3-L1 adipocytes. Brain-derived neurothrophic factor did not affect either glucose uptake or gluconeogenesis in these cells.
Conclusion/interpretation: These data indicate that brain-derived neurothrophic factor rapidly enhances insulin signal transduction in liver and shows hypoglycaemic action in diabetic mice.
He W, Chang F, Wang T, Sun B, Chen R, Zhao L PLoS One. 2024; 19(4):e0297785.
PMID: 38648255 PMC: 11034647. DOI: 10.1371/journal.pone.0297785.
Biswas M, Vanwong N, Sukasem C Front Pharmacol. 2024; 14:1285967.
PMID: 38375208 PMC: 10875059. DOI: 10.3389/fphar.2023.1285967.
Fatma R, Chauhan W, Shahi M, Afzal M Front Neurol. 2023; 13:1035885.
PMID: 36742047 PMC: 9894895. DOI: 10.3389/fneur.2022.1035885.
Is Brain-Derived Neurotrophic Factor a Metabolic Hormone in Peripheral Tissues?.
Iu E, Chan C Biology (Basel). 2022; 11(7).
PMID: 36101441 PMC: 9312804. DOI: 10.3390/biology11071063.
Brain-derived neurotrophic factor (BDNF): a multifaceted marker in chronic kidney disease.
Afsar B, Afsar R Clin Exp Nephrol. 2022; 26(12):1149-1159.
PMID: 36030459 DOI: 10.1007/s10157-022-02268-z.